Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
FKBP prolyl isomerase family member 15 (FKBP15) is a cytosolic protein encoded by the FKBP15 gene. It is predicted to enable actin-binding activity and has a domain structure consistent with FKBP-type peptidyl-prolyl isomerases, though it appears to be inactive as a PPIase in humans. FKBP15 is involved in the cytoskeletal organization of neuronal growth cones and participates in the transport of early endosomes at the interface of actin and microtubule based movement. While several members of the FKBP family play important roles in immunosuppression, protein folding, and cell signaling, FKBP15's exact mechanism and drug interactions remain less defined. Disorders associated with FKBP15 include hereditary spastic paraplegia, a neurodegenerative condition affecting motor neurons
Null for FKBP15 specifically regarding known drug mechanisms, as there is no evidence it interacts directly with clinically used drugs. General FKBP mechanism (for other family members): Drug binding leading to immunosuppression via calcineurin inhibition
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on FKBP prolyl isomerase family member 15 (FKBP15).